213 related articles for article (PubMed ID: 35269457)
1. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
[TBL] [Abstract][Full Text] [Related]
2. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells Generated in the Presence of Platelet Lysate Have a Reduced Type 1 Polarization Capacity.
Tešić N; Pekle Simonič I; Roškar K; Rožman P; Švajger U
Immunol Invest; 2020 Apr; 49(3):215-231. PubMed ID: 31170833
[TBL] [Abstract][Full Text] [Related]
4. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
[TBL] [Abstract][Full Text] [Related]
5. Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.
Lövgren T; Sarhan D; Truxová I; Choudhary B; Maas R; Melief J; Nyström M; Edbäck U; Vermeij R; Scurti G; Nishimura M; Masucci G; Karlsson-Parra A; Lundqvist A; Adamson L; Kiessling R
Cancer Immunol Immunother; 2017 Oct; 66(10):1333-1344. PubMed ID: 28601925
[TBL] [Abstract][Full Text] [Related]
6. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
Boullart AC; Aarntzen EH; Verdijk P; Jacobs JF; Schuurhuis DH; Benitez-Ribas D; Schreibelt G; van de Rakt MW; Scharenborg NM; de Boer A; Kramer M; Figdor CG; Punt CJ; Adema GJ; de Vries IJ
Cancer Immunol Immunother; 2008 Nov; 57(11):1589-97. PubMed ID: 18322684
[TBL] [Abstract][Full Text] [Related]
7. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
8. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.
Grauer O; Pöschl P; Lohmeier A; Adema GJ; Bogdahn U
J Neurooncol; 2007 Apr; 82(2):151-61. PubMed ID: 17106649
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.
Luft T; Luetjens P; Hochrein H; Toy T; Masterman KA; Rizkalla M; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
Int Immunol; 2002 Apr; 14(4):367-80. PubMed ID: 11934873
[TBL] [Abstract][Full Text] [Related]
11. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
[TBL] [Abstract][Full Text] [Related]
12. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity.
Kim HJ; Kim HO; Lee K; Baek EJ; Kim HS
Vaccine; 2010 Apr; 28(16):2877-86. PubMed ID: 20156531
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-α promotes survival and phenotypic maturation of poly(I:C)-treated dendritic cells but impairs their Th1 and Th17 polarizing capability.
Thorne A; Tomić S; Pavlović B; Mihajlović D; Džopalić T; Čolić M
Cytotherapy; 2015 May; 17(5):633-46. PubMed ID: 25559144
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E
Gierlich P; Lex V; Technau A; Keupp A; Morper L; Glunz A; Sennholz H; Rachor J; Sauer S; Marcu A; Grigoleit GU; Wölfl M; Schlegel PG; Eyrich M
Cancer Immunol Immunother; 2020 Jun; 69(6):1029-1042. PubMed ID: 32100075
[TBL] [Abstract][Full Text] [Related]
15. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.
Means TK; Hayashi F; Smith KD; Aderem A; Luster AD
J Immunol; 2003 May; 170(10):5165-75. PubMed ID: 12734364
[TBL] [Abstract][Full Text] [Related]
16. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
Zhu M; Xu W; Su H; Huang Q; Wang B
Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
[TBL] [Abstract][Full Text] [Related]
17. Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale.
Kaka AS; Foster AE; Weiss HL; Rooney CM; Leen AM
J Immunother; 2008 May; 31(4):359-69. PubMed ID: 18391760
[TBL] [Abstract][Full Text] [Related]
18. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma dose-dependently inhibits prostaglandin E2-mediated dendritic-cell-migration towards secondary lymphoid organ chemokines.
Alder J; Hahn-Zoric M; Andersson BA; Karlsson-Parra A
Vaccine; 2006 Nov; 24(49-50):7087-94. PubMed ID: 16889876
[TBL] [Abstract][Full Text] [Related]
20. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
He M; Soni B; Schwalie PC; Hüsser T; Waltzinger C; De Silva D; Prinz Y; Krümpelmann L; Calabro S; Matos I; Trumpfheller C; Bacac M; Umaña P; Levesque MP; Dummer R; van den Broek M; Gasser S
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]